NASDAQ:NAUT | Free Cash Flow | Nautilus Biotechnology, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-06-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$13.1M$510,000.00-$13.61M
2025-12-31-$12.38M$244,000.00-$12.62M
2025-03-31-$13.94M$219,000.00-$14.16M
2024-12-31-$14.31M$254,000.00-$14.56M
2024-03-31-$16.27M$647,000.00-$16.91M
2023-12-31-$13.9M$413,000.00-$14.31M
2023-03-31-$12.52M$692,000.00-$13.22M
2022-12-31-$10.38M$229,000.00-$10.61M
2022-03-31-$12.34M$481,000.00-$12.82M
2021-12-31-$10.52M$986,000.00-$11.51M
2021-03-31-$6.25M$482,000.00-$6.74M
2020-12-31-$4.73M$304,000.00-$5.03M
2020-06-30$0.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$50.7M$1.28M-$51.97M
2024-12-31-$59.15M$2.12M-$61.27M
2023-12-31-$51.71M$2.44M-$54.15M
2022-12-31-$45.81M$2.32M-$48.13M
2021-12-31-$39.24M$2.27M-$41.51M
2020-12-31-$14M$921,000.00-$14.92M